Edition:
United States

Iovance Biotherapeutics Inc (IOVA.OQ)

IOVA.OQ on NASDAQ Stock Exchange Global Market

9.85USD
12:39pm EST
Change (% chg)

$-0.06 (-0.66%)
Prev Close
$9.92
Open
$10.01
Day's High
$10.28
Day's Low
$9.81
Volume
128,968
Avg. Vol
438,477
52-wk High
$19.80
52-wk Low
$7.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.356
Jun '18 0.00 -0.340
Mar '18 0.00 -0.314
FY 2017 Dec '17 0.00 -0.355
Sep '17 0.00 -0.350
Jun '17 0.00 -0.374
Mar '17 0.00 -0.332
FY 2016 Dec '16 0.00 -0.252
Sep '16 0.00 -1.154
Jun '16 0.00 -0.226
Mar '16 0.00 -0.142
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 5 0.00 0.00 0.00 0.00
Quarter Ending Mar-19 2 0.00 0.00 0.00 --
Year Ending Dec-18 6 0.00 0.00 0.00 0.00
Year Ending Dec-19 5 0.00 0.00 0.00 10.00
Earnings (per share)
Quarter Ending Dec-18 6 -0.30 -0.22 -0.34 -0.33
Quarter Ending Mar-19 3 -0.30 -0.23 -0.38 -0.32
Year Ending Dec-18 6 -1.29 -1.23 -1.32 -1.40
Year Ending Dec-19 6 -1.22 -0.93 -1.50 -1.35
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.39
P/E High - Last 5 Yrs. -- 148.17 46.24
P/E Low - Last 5 Yrs. -- 47.84 24.59
Beta 4.58 1.08 0.91
Price to Sales (TTM) -- 49.58 6.22
Price to Book (MRQ) 3.81 10.17 5.20
Price to Tangible Book (MRQ) 4.28 13.83 6.74
Price to Cash Flow (TTM) -- 52.85 24.17
% Owned Institutions 74.69 3.75 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 130.06 8.17
Sales (TTM) vs TTM 1 Yr. Ago -- 47.89 6.50
Sales - 5 Yr. Growth Rate -- 22.79 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago -65.35 75.90 23.08
EPS (TTM) vs TTM 1 Yr. Ago -199.13 -- --
EPS - 5 Yr. Growth Rate -- 12.04 10.49
Capital Spending - 5 Yr. Growth Rate 117.78 9.25 14.58

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 15.29 3.44 3.10
LT Debt to Equity (MRQ) 0.00 18.69 11.49
Total Debt to Equity (MRQ) 0.00 31.36 16.03
Interest Coverage (TTM) -- -43.32 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.37 54.44
Gross Margin - 5 Yr. Avg. -- 60.62 52.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -109.98 13.16
Operating Margin (TTM) -- -184.99 6.07
Operating Margin - 5 Yr. Avg. -- -126.42 8.47
Pre-Tax Margin (TTM) -- -175.75 7.02
Pre-Tax Margin - 5 Yr. Avg. -- -132.58 8.71
Net Profit Margin (TTM) -- -182.49 3.12
Net Profit Margin - 5 Yr. Avg. -- -136.98 4.91
Effective Tax Rate (TTM) -- 21.47 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.43 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,649,007 873,056,423
Net Income/Employee (TTM) -1,539,353 653,334 103,484,349
Receivable Turnover (TTM) -- 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) 0.00 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -47.36 6.47 11.45
Return on Assets - 5 Yr. Avg. -46.95 5.54 12.50
Return on Investment (TTM) -49.36 9.01 14.96
Return on Investment - 5 Yr. Avg. -52.23 6.87 16.23
Return on Equity (TTM) -80.46 10.15 16.52
Return on Equity - 5 Yr. Avg. -77.17 8.41 17.37
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -197.33 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Iovance Biotherapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 7.53 3.83 99 98
13 Week 15.44 9.82 99 94
26 Week 19.85 10.74 99 98
52 Week 1.29 -14.15 99 68
YTD 12.95 -0.81 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 78.92%
# of Holders: 191
Total Shares Held: 97,205,446
3 Mo. Net Change: 7,428,741
# New Positions: 27
# Closed Positions: 25
# Increased Positions: 91
# Reduced Positions: 67
# Net Buyers: 24
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.